Literature DB >> 14638995

Mycobacterial infection in MyD88-deficient mice.

Isamu Sugawara1, Hiroyuki Yamada, Satoru Mizuno, Kiyoshi Takeda, Shizuo Akira.   

Abstract

MyD88 is an adaptor protein that plays a major role in TLR/IL-1 receptor family signaling. To understand the role of MyD88 in the development of murine tuberculosis in vivo, MyD88 knockout (KO) mice aerially were infected with Mycobacterium tuberculosis. Infected MyD88 mice were not highly susceptible to M. tuberculosis infection, but they developed granulomatous pulmonary lesions with neutrophil infiltration which were larger than those in wild-type (WT) mice (P < 0.01). The pulmonary tissue levels of mRNA for iNOS and IL-18 were slightly lower, but levels of mRNA for IL-1 beta, IL-2, IL-4, IL-6, IL-10, IFN-gamma, and TGF-beta were higher in MyD88 KO mice. IFN-gamma, TNF-alpha, IL-1 beta, and IL-12 also were high in the sera of MyD88 KO mice. There were no statistically significant differences in the expression of TNF-alpha, IL-12, and ICAM-1 mRNA between MyD88 KO and WT mice. Thus, MyD88 deficiency did not influence the development of murine tuberculosis. NF-kappa B activity was similar in the alveolar macrophages from the lung tissues of MyD88 KO and WT mice. Also, there may be a TLR2-specific, MyD88-independent IL-1 receptor/TLR-mediated pathway to activate NF-kappa B in the host defense against mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638995     DOI: 10.1111/j.1348-0421.2003.tb03450.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  25 in total

Review 1.  TB, or not TB: that is the question -- does TLR signaling hold the answer?

Authors:  Terence M Doherty; Moshe Arditi
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 2.  Role of interleukin-18 in the pathophysiology of allergic diseases.

Authors:  Nathan L Sanders; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2016-07-15       Impact factor: 7.638

3.  Streptomycin-dependent exhibition of cytokine-inducing activity in streptomycin-dependent Mycobacterium tuberculosis strain 18b.

Authors:  Yutaka Fukasawa; Ikuo Kawamura; Ryosuke Uchiyama; Kazuhiro Yamamoto; Taijin Kaku; Takanari Tominaga; Takamasa Nomura; Satoshi Ichiyama; Takayuki Ezaki; Masao Mitsuyama
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

Authors:  Cecile M Fremond; Vladimir Yeremeev; Delphine M Nicolle; Muazzam Jacobs; Valerie F Quesniaux; Bernhard Ryffel
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 5.  MyD88 in Mycobacterium tuberculosis infection.

Authors:  Jorge L Cervantes
Journal:  Med Microbiol Immunol       Date:  2017-02-20       Impact factor: 3.402

6.  A role for IL-18 in protective immunity against Mycobacterium tuberculosis.

Authors:  Bianca E Schneider; Daniel Korbel; Kristine Hagens; Markus Koch; Bärbel Raupach; Jana Enders; Stefan H E Kaufmann; Hans-Willi Mittrücker; Ulrich E Schaible
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

Review 7.  Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?

Authors:  William R Berrington; Thomas R Hawn
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

8.  Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.

Authors:  Andrés Obregón-Henao; Kimberly A Arnett; Marcela Henao-Tamayo; Lisa Massoudi; Elizabeth Creissen; Koen Andries; Anne J Lenaerts; Diane J Ordway
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

Review 9.  Innate immunity in tuberculosis: host defense vs pathogen evasion.

Authors:  Cui Hua Liu; Haiying Liu; Baoxue Ge
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

Review 10.  Modulation of adaptive immunity with Toll-like receptors.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Semin Immunol       Date:  2009-06-06       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.